Enanta Pharmaceuticals (ENTA) Net Margin Growth (1y) (2013 - 2026)
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 4,168.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 673.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 2,208.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -392.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 29,636.00 |
| 10 | Enanta Pharmaceuticals | 404.93 Mn | 215.43 Mn | - | -3,613.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,613.00 |
| Mar 31, 2026 | 7,542.00 |
| Dec 31, 2025 | 6,730.00 |
| Sep 30, 2025 | 7,311.00 |
| Jun 30, 2025 | 2,640.00 |
| Mar 31, 2025 | 3,099.00 |
| Dec 31, 2024 | 5,413.00 |
| Sep 30, 2024 | -4,754.00 |
| Jun 30, 2024 | 8,070.00 |
| Mar 31, 2024 | 2,893.00 |
| Dec 31, 2023 | -6,266.00 |
| Sep 30, 2023 | -1,886.00 |
| Jun 30, 2023 | -4,404.00 |
| Mar 31, 2023 | -3,214.00 |
| Dec 31, 2022 | -1,398.00 |
| Sep 30, 2022 | -2,585.00 |
| Jun 30, 2022 | -5,164.00 |
| Mar 31, 2022 | 65.00 |
| Dec 31, 2021 | -8,269.00 |
| Sep 30, 2021 | 2,040.00 |